Company: SION
Filing Date: 2025-05-12
Form Type: 8-K
Source: 0002036042-25-000014
Chunk: 1

Company: Sionna Therapeutics, Inc.
Filing Date: 2025-05-12
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  99.1      Press Release of Sionna Therapeutics, Inc. dated May 12, 2025.                
 ──────────────────────────────────────────────────────────────────────────────────────────
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document).  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                                      Sionna Therapeutics, Inc.  
  Date: May 12, 2025      By:         /s/ Jennifer Fitzpatrick   
                          Name:       Jennifer Fitzpatrick       
                          Title:      Chief Legal Officer